Your browser doesn't support javascript.
loading
Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
Crouch, Simon; Painter, Daniel; Barrans, Sharon L; Roman, Eve; Beer, Philip A; Cooke, Susanna L; Glover, Paul; Van Hoppe, Suzan J L; Webster, Nichola; Lacy, Stuart E; Ruiz, Camilo; Campbell, Peter J; Hodson, Daniel J; Patmore, Russell; Burton, Cathy; Smith, Alexandra; Tooze, Reuben M.
Afiliação
  • Crouch S; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Painter D; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Barrans SL; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Roman E; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Beer PA; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Cooke SL; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Glover P; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Van Hoppe SJL; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Webster N; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Lacy SE; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Ruiz C; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Hodson DJ; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Patmore R; Queen's Centre for Oncology and Haematology, Castle Hill Hospital, Cottingham, United Kingdom.
  • Burton C; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Smith A; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Tooze RM; Section of Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom.
Blood Adv ; 6(21): 5716-5731, 2022 11 08.
Article em En | MEDLINE | ID: mdl-35363872
Follicular lymphoma (FL) is morphologically and clinically diverse, with mutations in epigenetic regulators alongside t(14;18) identified as disease-initiating events. Identification of additional mutational entities confirms this cancer's heterogeneity, but whether mutational data can be resolved into mechanistically distinct subsets remains an open question. Targeted sequencing was applied to an unselected population-based FL cohort (n = 548) with full clinical follow-up (n = 538), which included 96 diffuse large B-cell lymphoma (DLBCL) transformations. We investigated whether molecular subclusters of FL can be identified and whether mutational data provide predictive information relating to transformation. DNA extracted from FL samples was sequenced with a 293-gene panel representing genes frequently mutated in DLBCL and FL. Three clusters were resolved using mutational data alone, independent of translocation status: FL_aSHM, with high burden of aberrant somatic hypermutation (aSHM) targets; FL_STAT6, with high STAT6 & CREBBP mutation and low aSHM; and FL_Com, with the absence of features of other subtypes and enriched KMT2D mutation. Analysis of mutation signatures demonstrated differential enrichment of predicted mutation signatures between subgroups and a dominant preference in the FL_aSHM subgroup for G(C>T)T and G(C>T)C transitions consistent with previously defined aSHM-like patterns. Of transformed cases with paired samples, 17 of 26 had evidence of branching evolution. Poorer overall survival (OS) in the aSHM group (P = .04) was associated with older age; however, overall tumor genetics provided limited information to predict individual patient risk. Our approach identifies 3 molecular subclusters of FL linked to differences in underlying mechanistic pathways. These clusters, which may be further resolved by the inclusion of translocation status and wider mutation profiles, have implications for understanding pathogenesis as well as improving treatment strategies in the future.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma Difuso de Grandes Células B / Neoplasias Hematológicas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Linfoma Difuso de Grandes Células B / Neoplasias Hematológicas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article